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Background: Induced hypotension (IH) had been used for decades in neurosurgery 
to reduce the risk for intraoperative blood loss and decrease blood replacement. 
More recently, this method fell out of favor because of concerns for cerebral and other 
end-organ ischemia and worse treatment outcomes. Other contributing factors to the 
decline in its popularity include improvements in microsurgical technique, widespread 
use of endovascular procedures, and advances in blood conservation and transfusion 
protocols. Permissive hypotension (PH) is still being used occasionally in neurosurgery; 
however, its role in current anesthesia practice remains unclear. Our objective was to 
describe contemporary utilization of IH and PH (collectively called PH) in clinical practice 
among members of the Society for Neuroscience in Anesthesiology and Critical Care 
(SNACC).
Methods: A questionnaire was developed and distributed among SNACC members 
that addressed practice patterns related to the use of PH. The responses were analyzed 
based on the number of individuals who responded to each specific question.
results: Of 72 respondents, 67.6% reported over 10 years of clinical experience, while 
15.5% reported 5–10 years of post-training experience. The respondents admitted to 
providing anesthesia for 300 (median) neurosurgical cases per year. PH was applied 
most commonly during open interventions on cerebral aneurysms (50.8%) and arterio-
venous malformations (46%). Seventy-three percent of respondents were not aware of 
any complications in their practice attributable to PH.
conclusion: PH is still being used in neuroanesthesia practice by some providers. 
Further research is justified to clarify the risks and benefits of PH in modern neuroanes-
thesia practice.
Keywords: permissive hypotension, anesthesia for neurosurgery, intraoperative blood pressure, controlled 
hypotension, intraoperative cerebral ischemia, intraoperative blood loss
Abbreviations: AVM, arteriovenous malformation; BP, blood pressure; EEG, electroencephalography; EP, evoked potentials; 
IH, induced hypotension; MBP, mean blood pressure; SNACC, Society for Neuroscience in Anesthesiology and Critical Care; 
POCD, postoperative cognitive dysfunction; PH, permissive hypotension; SBP, systolic blood pressure.
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inTrODUcTiOn
In 1918, Canon and his colleagues introduced the concept of per-
missive hypotension (PH) as a resuscitation strategy used in the 
acute phase of traumatic hemorrhagic shock (as cited in ref. 1).
Permissive hypotension and its variation known as con-
trolled or induced hypotension (IH) were used in neurosurgical 
practice for decades to reduce intraoperative blood loss, create a 
clearer surgical view, and relax the aneurysmal neck to facilitate 
clipping. The main distinction between PH and IH is mostly 
quantitative. PH (formerly known as moderate level of con-
trolled hypotension) usually refers to an intraoperative blood 
pressure (BP) reduction of no more than 20–30% of baseline 
values. Usually, it can be achieved by adjustments in anesthe-
sia without using vasoactive drugs. IH, on the other hand, 
commonly refers to a deeper level of controlled BP decrease 
requiring titrated infusion of vasoactive medications. Potential 
hazards of these methods include increased risk of cerebral 
ischemia, retraction injury, inadequate local hemostasis with 
risk of rebleeding, cardiovascular complications, postoperative 
renal dysfunction, and others. Additional contributing factors 
to decreased popularity of both methods were improvements 
in microsurgical technique and equipment, routine use of 
temporary clipping of the feeding vessels during dissection, 
and mobilization of the aneurysmal neck as well as significant 
advances in endovascular techniques, anesthesia, and neuro-
imaging methods. As a result, IH subsequently fell out of favor. 
PH, on the other hand, was not abandoned completely and is 
still being applied with uncertain frequency worldwide mostly 
being advocated by surgeons.
It would be useful and of practical interest to determine the 
practice patterns of PH (and IH) in modern day neurosurgical 
anesthesia.
The main objective of the study was to conduct a survey to 
determine the role of PH (and IH) in clinical practice among 
Society for Neuroscience in Anesthesiology and Critical Care 
(SNACC) members and analyze practical aspects of various 
approaches to the method. In an attempt to reduce the variability 
of responses, which would make data analysis more problematic, 
we used the term PH for both paths of intraoperative controlled 
BP reduction.
ParTiciPanTs anD MeThODs
The survey was approved by the Institutional Review Board of the 
Ohio State University Wexner Medical Center.
A 26-item questionnaire that addressed the principle aspects 
of PH was created and sent to SNACC to be forwarded to its 
active members. SNACC announced via emails the upcoming 
survey encouraging its members to participate. The survey was 
conducted for 4  weeks during October–November of 2014. 
SNACC distributed the questionnaire among its members 
and used Survey Monkey to collect anonymous responses and 
conduct a preliminary analysis of the results. These results were 
then forwarded to our team to complete the data analysis. Not all 
respondents answered all questions, so all calculations were made 
based on the actual number of respondents for each question. No 
detailed statistical tests were applied considering survey specifics 
and variability of answers.
resUlTs
Overall, 72 participants (13% of SNACC members) completed 
the survey. The results are presented in Table 1 and Figures 1–11.
Eighty-nine percent of respondents represented the USA, 
Canada, the European continent, and Australia (Figure 1). The 
majority of respondents (83.1%) stated to have at least 5 years of 
clinical experience in neurosurgical anesthesiology (Figure 2). 
According to responses, the participating anesthesiologists 
managed 300 (median) neurosurgical cases per year and 
worked in hospitals covering neurosurgical procedures under 
anesthesia for approximately 1,500 patients per year (Figures 3 
and 4). The intraoperative PH had been reportedly used by 
50.8% during open aneurysmal clipping, while 46% applied 
the method during surgery on arteriovenous malformations 
(AVM) (Figure  5). The method was applied less frequently 
with other procedures. Among respondents, 67.2% of anesthe-
siologists used systolic blood pressure (SBP) value to conduct 
PH and up to 70.2% of them maintained the SBP level above 
90 mmHg. Less frequently (29.8% of respondents), SBP target 
values <90  mmHg were used (Figure  6). More commonly 
(90.8%), the mean blood pressure (MBP) was used to control 
the level of hypotension, and 70% preferred maintaining the 
MBP ≥60 mmHg (Figure 7).
Seventy-three percent of respondents were not aware of 
any adverse effects encountered during their practice that 
could directly be attributed to the use of PH in their patients 
(Figure  8). The reported adverse effects of PH are shown in 
Figure 9.
Most commonly, raw recordings or processed electroencepha-
lography (EEG), evoked potentials (EP), and cerebral oximetry 
were used for intraoperative neurophysiological monitoring 
during PH (Figure 10).
The majority of anesthesiologists (79.4%) reported using 
PH in patients with chronic arterial hypertension, and most 
of them tolerated 20–30% decrease in SBP or MBP during the 
procedure.
One-third of the respondents applied PH when the patient 
was not in a horizontal position (i.e., sitting, head up, etc.). Less 
frequently (14.5%), PH was used in combination with other 
techniques to reduce the blood loss (see Table  1). Techniques 
used to decrease the risks of PH included hydration, maintaining 
adequate hematocrit, intraoperative monitoring, limiting the 
time of PH, hypothermia, and others. Various drugs were report-
edly used to induce and maintain PH (Figure 11).
DiscUssiOn
Permissive hypotension had been used for decades in neuro-
surgery in an attempt to reduce intraoperative blood loss, lower 
blood transfusion rates, and improve operative conditions. With 
time, potential adverse effects and limitations of PH were better 
understood. Increased concerns for cerebral ischemic damage, 
TaBle 1 | Twenty-six-item questionnaire and results of the conducted survey.
Question answer responses 
(%)
N responded respondents 
(total)
1. What is the country of your home institution? Figure 1 68
2. Do you use “permissive” or “induced” hypotension during any of the following surgeries?
Figure 5
63
3. If you responded in the previous question that you use permissive or induced hypotension 
(IH) during “other procedures,” please state the types of procedures
5
4. Do you use invasive arterial BP monitoring (arterial line) when you perform  
permissive or IH?
Always
Sometimes
Never
87.3
9.5
3.2
55
6
2
63
5. Where do you locate the pressure transducer in patients who are not in a horizontal position 
if an arterial line is used?
At the heart level
At the ear level
16.9
83.1
11
54
65
6. Do you use SBP (versus mean blood pressure) as a guide in cases where you perform 
permissive or IH?
Always
Sometimes
Never
17.2
50.0
32.8
11
32
21
64
7. If you use systolic arterial pressure as a guide, what is your target during permissive or IH in 
non-hypertensive patients?
Figure 6
47
8. Do you use mean arterial BP as a guide during permissive or IH? Always 47.7 31 65
Sometimes 43.1 28
Never 9.2 6
9. If you use mean arterial pressure as a guide, what is your target during permissive or IH in 
non-hypertensive patients?
Figure 7
60
10. What drugs do you use to reach the target BP value? Figure 11 66
11. Do you use any devices during surgery with permissive or IH to monitor the integrity of 
cerebral perfusion?
Figure 10
50
12. Do you perform permissive or IH in patients with chronic hypertension? Always 2.9 2 68
Sometimes 76.5 52
Never 20.6 14
13. If you perform permissive or IH in hypertensive patients, do you change the minimum 
target BP with respect to non-hypertensive patients?
Yes
No
I do not use permissive hypotension in hypertensive patients
80.0
4.6
15.4
52
3
10
65
14. If you answered “YES” to the last question, please mark the option that best fits your 
practice
Tolerate decreases in systolic or mean pressure to 20% of basal values
Tolerate decreases in systolic or mean pressure to 30% of basal values
Tolerate decreases in systolic or mean pressure to 40% of basal values
50.0
46.3
3.7
27
25
2
54
15. Are you aware of any complications in your patients treated with intraoperative permissive 
or IH that may be associated with this technique?
Figure 8
67
(Continued)
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Question answer responses 
(%)
N responded respondents 
(total)
16. If you answered “YES” to the prior question, please specify the complication Figure 9 19
17. In your opinion, which of the following conditions are contraindications for permissive or 
IH?
Uncontrolled arterial hypertension
Renal insufficiency
Coronary artery disease
Carotid insufficiency
70.3
50.0
73.4
89.1
45
32
47
57
64
18. Do you use permissive or IH during procedures when the patient is NOT in the horizontal 
position?
Yes
No
32.4
67.7
22
46
68
19. If the answer was “YES” to the prior question, please specify the other positions many 
respondents reported more than one position
Head up
Any position requested by surgeon
Beach Chair
Prone
Park bench
Lateral
Sitting/semi-sitting
Supine with back up
Spine surgery
Positioning for shoulder surgery (will keep SBP ≥  100 mmHg)
27.3
4.5
9.1
18.2
27.3
13.6
4.5
4.5
4.5
4.5
6
1
2
4
6
3
1
1
1
1
22
20. Do you use permissive or IH in combination with other methods to prevent intraoperative 
blood loss (e.g., hemodilution)?
Yes
No
14.5
85.5
10
59
69
21. If you answered “YES” to the prior question, what techniques do you use? Propofol and remifentanil (not in neurosurgery) 14.3 1 7
Hemodilution 14.3 1
Low-dose adrenalin (epinephrine) infusion “to maintain the cardiac 
output and peripheral tissue perfusion”
14.3 1
Tranexamic acid 28.6 2
Methods to improve venous return (unspecified) 14.3 1
Adenosine 14.3 1
22. Do you use any special techniques to decrease the risk of side effects of permissive or IH 
(e.g., limiting the duration)?
I never use permissive hypotension
Yes
No
11.6
46.4
42.0
8
32
29
69
23. If you answered “YES” to the prior question, what techniques do you use? Hydration 6.3 2 32
Maintaining adequate hematocrit 9.4 3
Additional monitoring (A-line, NIRS, neuromonitoring, EEG burst 
suppression, SSEP)
15.6 5
Limit duration (a few minutes to less than 2 h) 62.5 20
Limit the extent of hypotension and adjust BP targets 18.8 6
Operated by experienced surgeon 3.1 1
Using only at the most critical points of surgery (clipping of the 
aneurysm, aneurysmal rupture, difficulty in controlling bleeding, post-
resection in AVMs, pedicle screw placement in spinal surgery, when 
requested by the surgeon)
12.5 4
(Continued)
TaBle 1 | continued
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FigUre 1 | geographical representation of respondents (68 
respondents).
FigUre 2 | experience of the respondents in the field of clinical 
anesthesia (71 respondents).
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cardiovascular complications, and kidney dysfunction attribut-
able to PH reduced its role in clinical practice. Furthermore, 
long term outcomes of using PH have never been reported. 
Nevertheless, the method was not abandoned completely and 
continued to be used, although with less popularity, by some 
anesthesiologists.
There is published evidence supporting the use of PH in ini-
tial management of multi-trauma patients including those with 
head injury and in cases with aortic aneurysm rupture (1, 2). 
The method has also proved its efficacy in maxillofacial surgery 
(3, 4). Stability of cerebral oxygenation was demonstrated during 
anesthetic-induced arterial hypotension (5).
Kertai and colleagues conducted a retrospective analysis of 
the clinical data of 16,263 patients who underwent non-cardiac 
surgery. They did not find any significant association between 
intermediate-term mortality and cumulative duration of low 
MBP below 75 mmHg (6). However, when that parameter was 
combined with cumulative duration of low bispectral index in a 
logistic regression model after adding the Cleveland Clinic Risk 
Index Score and age, low MBP showed a significant correlation 
with the risk of 30-day mortality (6).
There are many studies that highlight the potential risks and 
detrimental effects of intraoperative arterial hypotension on end-
organ function and treatment outcome. Walsh and colleagues 
analyzed the data of 33,330 non-cardiac surgeries and found that 
even short durations of an intraoperative MBP <55 mmHg were 
FigUre 4 | The reported number of neurosurgical procedures per year during which the respondents provided general anesthesia (68 respondents). 
Median: 300, 25–75% range: 150–400.
FigUre 3 | The reported number of neurosurgical procedures under general anesthesia per year in the institutions where the respondents work (66 
respondents). Median: 1,500, 25–75% range: 800–2,800.
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associated with acute kidney injury and myocardial injury (7). 
Sessler et al. concluded that low minimal alveolar concentration 
of the anesthetic combined with a low MBP, and low bispectral 
index is an ominous predictor of excessive hospital length of stay 
and postoperative mortality (8).
Sun and colleagues conducted a retrospective cohort study 
in 5,127 patients undergoing non-cardiac surgery and described 
the association between intraoperative hypotension and acute 
kidney injury (9). The findings suggested an increased risk of 
postoperative acute kidney injury when the intraoperative MBP 
FigUre 8 | seventy-three percent of respondents were not aware of 
any complications among their patients treated with intraoperative 
permissive or induced hypotension that could be attributed to the 
technique. Twenty-seven percent of respondents were aware of such cases 
in their practice (67 respondents).
FigUre 7 | Mean blood pressure target values during anesthesia 
among normotensive patients (60 respondents).
FigUre 6 | systolic blood pressure target values during anesthesia 
among non-hypertensive patients (47 respondents).
FigUre 5 | Procedures when permissive hypotension (Ph) had been 
used (63 respondents). TPS, transsphenoidal pituitary surgery; AVM, 
arteriovenous malformations; NVP, neurovascular procedures; other—skull 
base and acoustic neuroma surgery, unspecified time periods and stages 
during open aneurysm surgeries, endovascular embolization, cases when 
adenosine-induced cardiac arrest was applied, unspecified cases when PH 
was requested by surgeon and when the method was deemed appropriate.
FigUre 9 | awareness of specific adverse effects related to 
intraoperative permissive hypotension in their practice among 
respondents (19 respondents). Stroke (13), POCD—postoperative 
cognitive dysfunction (11), renal insufficiency (6), coronary ischemia (9), 
other—possible cognitive dysfunction (1), rhabdomyolysis (1), postoperative 
bleeding (1), postoperative visual loss (1).
FigUre 10 | Modalities of monitoring used during intraoperative 
permissive hypotension. Electroencephalography (EEG)—
encephalography, processed EEG/BIS—processed encephalography/
bispectral index. Fifty respondents (three non-relevant responses were 
excluded).
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was <60 mmHg for over 20 min and <55 mmHg for more than 
10  min. However, the study included patients with variable 
premorbid conditions undergoing different types of procedures 
who had diverse causes of intraoperative hypotension. With such 
FigUre 11 | Drugs used to reach target blood pressure (BP) values 
during permissive hypotension (66 respondents). Other drugs included: 
magnesium, clevidipine, phentolamine, dexmedetomidine (two respondents), 
adenosine, and all of the listed medications (one respondent).
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variability within the group, it would be difficult to extrapolate 
the data on elective neurosurgical cases undergoing PH under a 
well-controlled setting.
Monk and colleagues conducted a retrospective cohort study 
to analyze the association between intraoperative arterial hypo-
tension and hypertension and 30-day postoperative mortality in 
patients who underwent non-cardiac surgery (10). The intraop-
erative hypotension, according to the authors, correlated with the 
risk of increased 30-day mortality. As with the above described 
study, these results cannot be unequivocally generalized for 
elective neurosurgical cases. Only 5.6% of the 18,756 patients 
had neurosurgical procedures. The study included patients with 
disseminated cancer, patients undergoing peripheral vascular 
surgery, and emergency cases. Many patients included in this 
study would not be proper candidates for PH. In addition, the 
mean age of the study group was 59.5 years, and subjects were 
predominantly male (92.8%). All these factors make the study 
conclusions less applicable to patients undergoing elective neuro-
surgical procedures with application of PH, and we think that this 
is a limitation of any large-scale database analyses that include 
multiple surgical pathologies and premorbid conditions.
Thus, significant controversy exists regarding the use of PH in 
elective neurosurgery. While intraoperative arterial hypotension 
is, in general, considered deleterious, some anesthesiologists 
continue to safely use PH in elective neurosurgery.
The results of our survey indicate that, despite heavy criticism, 
PH is still being occasionally used in modern day neuroanesthe-
sia practice, and the main area of its application is neurovascular 
surgery. Those respondents who refrain from using PH in their 
practice, presumably, take into consideration the above discussed 
potential detrimental effects of the method or use alternative 
methods to avoid major intraoperative bleeding. Specific requests 
by the surgical team and local preferences are additional contrib-
uting factors to decision-making.
The vast majority of our respondents were from North America, 
Europe, and Australia. Most of them had significant experience in 
neurosurgical anesthesia and worked in major hospitals dealing 
with a large number of neurosurgical patients (Figures 3 and 4). 
Therefore, it seems reasonable to assume that they used similar 
standards of patient care, and no bias had been introduced in the 
study related to substandard health care.
According to the survey results, the main area where PH is 
still being used is cerebrovascular surgery (Figure 5). Procedures 
performed on cerebral vessels carry the risk of acute and mas-
sive blood loss, intraoperative brain swelling, and flooding the 
operative field, which may make the surgical control of bleeding 
problematic. In such circumstances, prophylactic or therapeutic 
PH may be lifesaving, and its immediate benefits may outweigh 
the well-known risks.
The detrimental effects of PH correlate with its extent and 
duration. We think that clinical judgment and experience with 
the method can help to maximize the benefits of PH and avoid 
its complications. Coordination with the stage of the surgical 
procedure, meticulous neurophysiological monitoring, and rea-
sonable limitation of duration and extent of PH are prerequisites 
to reduce the risk of ischemic damage to the brain and other vital 
organs. The role of surgical technique cannot be overestimated 
in minimizing the duration of PH and preventing retraction 
ischemia during PH.
The majority of survey respondents who use PH prefer a mod-
erate level of hypotension with ~20% decrease of SBP or MBP. On 
the other hand, multiple reports indicate that short periods of 
extreme hypotension or blood flow cessation can safely be used 
in selective cases without causing neurological deterioration or 
increasing cardiac morbidity (11–14). For example, adenosine 
can be safely used in cases when temporary clipping of the feeding 
vessel is not technically possible or when an aneurysmal rupture 
occurs during the dissection (11). Guinn et al. used 0.24–0.42 mg/
kg of adenosine to achieve extreme hypotension defined as SBP 
<60 mmHg during 30–60 s (12). This time period was usually 
sufficient to clip the aneurysm. According to the authors, satisfac-
tory operative exposure was achieved in every case. Apparently, 
the safe time period for using a moderate degree of PH (20–30% 
less than baseline) will be longer.
At both the Ohio State University Wexner Medical Center 
and Mayo Clinic, we prefer maintaining the BP at least above the 
lower normal limits during neurosurgical procedures trying to 
avoid MBP decrease below 70 mmHg. In some cases, particularly 
in spinal surgery, we commonly use higher BP target values to 
ensure adequate perfusion pressure during specific stages of 
surgery.
Many patients undergoing stereotactic placement of 
stimulation electrodes for management of Parkinson’s disease 
are of advanced age and present with preexisting cardiovascular 
pathologies and chronic arterial hypertension. Another impor-
tant cause of preoperative arterial hypertension is the white-coat 
hypertension (15). In this group of patients, at the Ohio State 
University Wexner Medical Center, we routinely use an infu-
sion of nicardipine or clevidipine to maintain SBP <110 mmHg 
during the stage of electrode insertion and target localization 
to minimize pulsatile brain movements and reduce the risk of 
bleeding. At Mayo Clinic, our goal during similar cases is also 
to avoid hypertension during deep brain stimulator lead place-
ment. We keep the SBP <140 mmHg by treating with intermittent 
doses of labetalol if needed. In general, the patients tolerate this 
9Soghomonyan et al. Permissive and Induced Hypotension in Neuroanesthesia
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slight reduction in SBP for a time period of about 30 min without 
any neurological or other complications. This correlates with 
the report of Williams-Russo and colleagues who studied 235 
older adults with comorbid medical illnesses undergoing elec-
tive primary total hip replacement with epidural anesthesia (16). 
The authors found no differences in cognitive, cardiac, or renal 
outcomes in groups with MBP range 45–55 and 55–70 mmHg.
Less frequently, PH had been used by our survey respond-
ents in spinal surgery and transsphenoidal procedures. While 
significant bleeding is not common in transsphenoidal surgery 
and usually can be locally controlled, intraoperative bleeding 
during spinal procedures is mostly of venous origin and induced 
arterial hypotension during such procedures is not necessarily 
accompanied by venous or intraosseous hypotension and less 
blood loss (17). The reduced efficacy along with the risk of spinal 
ischemia makes PH less applicable for spinal surgery. Similarly, 
Fearon et  al. found no differences in transfusion requirements 
between hypotensive and normotensive groups of pediatric 
patients undergoing craniosynostosis correction (18). Again, one 
possible explanation would be the predominantly venous origin 
of bleeding in this patient group.
Seventy-three percent of respondents were not aware of any 
adverse effects directly related to PH in their practice. However, 
the survey did not include specific questions to clarify postop-
erative follow-up of the patients by the anesthesia team. In many 
medical centers, the postanesthesia follow-up is limited to post-
operative day 1, which may limit the ability of the anesthesiologist 
to reveal all possible adverse effects of PH. The most commonly 
encountered complications of PH were postoperative cognitive 
dysfunction (POCD) and stroke (Figure 9). However, the ques-
tionnaire did not contain any specific questions about POCD, 
and it was unclear which criteria were used by the respondents 
to diagnose POCD in their patients and whether any preop-
erative assessments of the cognitive status were made. Various 
modifications of EEG, cerebral oximetry, and EP were used by 
most anesthesiologists to monitor the course of PH (Figure 10). 
While using modalities of neurophysiological monitoring, one 
should always keep in mind the limitations of each method 
including the possibility of false positive and false negative results 
(19). Nevertheless, multi-modality monitoring during PH is an 
essential component of anesthesia management and is aimed at 
reducing the risks of ischemic damage to the neural structures.
Various drugs were used by survey participants to induce and 
maintain PH (Figure  11). We believe that direct vasodilators 
including clevidipine, nicardipine, sodium nitroprusside, and 
others are advantageous in PH management due to their high 
efficacy, ease of titration, and ability to improve the microcircula-
tory flow (20–22). Selective calcium channel blockers have the 
advantage of selective arterial vasodilation with minimal effects 
on cerebral and spinal perfusion pressures. It is well known that 
cerebral blood flow is maintained at a lower MBP when hypo-
tension is induced by vasodilators than when it is induced by 
hemorrhage (23, 24).
Whenever a decision is made to use PH during surgery, certain 
precautions should be taken to decrease the associated risks. 
Minimizing the duration and extent of PH, strict coordination 
of work with the surgeon, multi-modal intraoperative monitor-
ing, and, possibly, pharmacological protection should be used 
to minimize the risk of adverse events. One of the respondents 
recommended limiting the MAP decrease to ≤30% baseline for 
no more than 10–25 min and limiting extreme MAP decrease to 
≤ 3–5 min. This time will usually suffice for reaching the surgical 
goals without a risk of ischemic damage. Optimizing the param-
eters of PH for various types of neurosurgical procedures can be 
an area of future research.
limitations
Limitations of this survey include the relatively small number of 
participants and possibility of selection bias due to more frequent 
participation of anesthesiologists using PH or having special 
interest in this method. Additionally, given the 13% response rate 
among SNACC members, it is possible that these findings are not 
an accurate reflection of practice patterns at all academic medi-
cal centers with a high volume neurosurgical practice. Also, the 
reported complication rate may not accurately reflect the actual 
incidence of complications related to PH.
cOnclUsiOn
Despite a decline in popularity, PH continues to be used in neu-
roanesthesia practice by some anesthesiologists with minimal 
reported early postoperative complication rate. Proper patient 
selection and adjustment of the extent and duration of arterial 
hypotension may increase the method’s safety and efficacy, limit 
the requirements in blood transfusions, and reduce the associ-
ated risks of end-organ ischemia. The main area of application 
for PH in neurosurgical practice remains neurovascular surgery. 
The fact that PH continues to be used in neuroanesthesia practice 
justifies a “second look” at the method and further research in 
this technique to clarify the existing controversies, develop 
evidence-based recommendations and safer patient-specific 
strategies for optimal intraoperative BP management in neuro-
surgical patients.
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